Cargando…

Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study

Sarcopenia and malnutrition are important determinants of increased fracture risk in osteoporosis. SARC-F and MNA-SF are well-established questionnaires for identifying patients at risk for these conditions. We sought to evaluate the feasibility and potential added benefit of such assessments as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Genest, Franca, Rak, Dominik, Bätz, Elisa, Ott, Kerstin, Seefried, Lothar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198508/
https://www.ncbi.nlm.nih.gov/pubmed/34071858
http://dx.doi.org/10.3390/jcm10112344
_version_ 1783707155696713728
author Genest, Franca
Rak, Dominik
Bätz, Elisa
Ott, Kerstin
Seefried, Lothar
author_facet Genest, Franca
Rak, Dominik
Bätz, Elisa
Ott, Kerstin
Seefried, Lothar
author_sort Genest, Franca
collection PubMed
description Sarcopenia and malnutrition are important determinants of increased fracture risk in osteoporosis. SARC-F and MNA-SF are well-established questionnaires for identifying patients at risk for these conditions. We sought to evaluate the feasibility and potential added benefit of such assessments as well as the actual prevalence of these conditions in osteoporosis patients. We conducted a cross-sectional, single-center study in female osteoporosis patients ≥ 65 years (SaNSiBaR-study). Results of the sarcopenia (SARC-F) and malnutrition (MNA-SF) screening questionnaires were matched with a functional assessment for sarcopenia and data from patients’ medical records. Out of 107 patients included in the analysis, a risk for sarcopenia (SARC-F ≥ 4 points) and a risk for malnutrition (MNA-SF ≤ 11 points) was found in 33 (30.8%) and 38 (35.5%) patients, respectively. Diagnostic overlap with coincident indicative findings in both questionnaires was observed in 17 patients (16%). As compared to the respective not-at-risk groups, the mean short physical performance battery (SPPB) score was significantly reduced in both patients at risk for sarcopenia (7.0 vs. 10.9 points, p < 0.001) and patients at risk for malnutrition (8.7 vs. 10.5 points, p = 0.005). Still, confirmed sarcopenia according to EWGSOP2 criteria was present in only 6 (6%) of all 107 patients, with only 3 of them having an indicative SARC-F score. Bone mineral density was not significantly different in any of the at-risk groups at any site. In summary, applying SARC-F and MNA-SF in osteoporosis patients appears to be a complementary approach to identify individuals with functional deficits.
format Online
Article
Text
id pubmed-8198508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81985082021-06-14 Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study Genest, Franca Rak, Dominik Bätz, Elisa Ott, Kerstin Seefried, Lothar J Clin Med Article Sarcopenia and malnutrition are important determinants of increased fracture risk in osteoporosis. SARC-F and MNA-SF are well-established questionnaires for identifying patients at risk for these conditions. We sought to evaluate the feasibility and potential added benefit of such assessments as well as the actual prevalence of these conditions in osteoporosis patients. We conducted a cross-sectional, single-center study in female osteoporosis patients ≥ 65 years (SaNSiBaR-study). Results of the sarcopenia (SARC-F) and malnutrition (MNA-SF) screening questionnaires were matched with a functional assessment for sarcopenia and data from patients’ medical records. Out of 107 patients included in the analysis, a risk for sarcopenia (SARC-F ≥ 4 points) and a risk for malnutrition (MNA-SF ≤ 11 points) was found in 33 (30.8%) and 38 (35.5%) patients, respectively. Diagnostic overlap with coincident indicative findings in both questionnaires was observed in 17 patients (16%). As compared to the respective not-at-risk groups, the mean short physical performance battery (SPPB) score was significantly reduced in both patients at risk for sarcopenia (7.0 vs. 10.9 points, p < 0.001) and patients at risk for malnutrition (8.7 vs. 10.5 points, p = 0.005). Still, confirmed sarcopenia according to EWGSOP2 criteria was present in only 6 (6%) of all 107 patients, with only 3 of them having an indicative SARC-F score. Bone mineral density was not significantly different in any of the at-risk groups at any site. In summary, applying SARC-F and MNA-SF in osteoporosis patients appears to be a complementary approach to identify individuals with functional deficits. MDPI 2021-05-27 /pmc/articles/PMC8198508/ /pubmed/34071858 http://dx.doi.org/10.3390/jcm10112344 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Genest, Franca
Rak, Dominik
Bätz, Elisa
Ott, Kerstin
Seefried, Lothar
Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study
title Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study
title_full Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study
title_fullStr Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study
title_full_unstemmed Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study
title_short Sarcopenia and Malnutrition Screening in Female Osteoporosis Patients—A Cross-Sectional Study
title_sort sarcopenia and malnutrition screening in female osteoporosis patients—a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198508/
https://www.ncbi.nlm.nih.gov/pubmed/34071858
http://dx.doi.org/10.3390/jcm10112344
work_keys_str_mv AT genestfranca sarcopeniaandmalnutritionscreeninginfemaleosteoporosispatientsacrosssectionalstudy
AT rakdominik sarcopeniaandmalnutritionscreeninginfemaleosteoporosispatientsacrosssectionalstudy
AT batzelisa sarcopeniaandmalnutritionscreeninginfemaleosteoporosispatientsacrosssectionalstudy
AT ottkerstin sarcopeniaandmalnutritionscreeninginfemaleosteoporosispatientsacrosssectionalstudy
AT seefriedlothar sarcopeniaandmalnutritionscreeninginfemaleosteoporosispatientsacrosssectionalstudy